NCT01515358View on ClinicalTrials.gov

A Study to Evaluate the Safety and Tolerability of LY3000328 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Healthy Volunteers
Interventions
DRUG

Placebo

Administered orally

DRUG

LY3000328

Administered orally

Trial Locations (1)

117597

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01515358 - A Study to Evaluate the Safety and Tolerability of LY3000328 in Healthy Participants | Biotech Hunter | Biotech Hunter